Story · Medicine & Biotech

Real-world external validation of the Society for Immunotherapy of Cancer (SITC) definitions of primary and secondary resistance to PD-1/PD-L1 inhibitors in patients with solid tumors

1 outlet · first reported by Research Square on

Purpose The Society for Immunotherapy of Cancer (SITC) definitions of primary and secondary resistance to PD-1/PD-L1 inhibitors are widely used but were independently evaluated mainly in melanoma. We assessed their prognostic performance in a real-world pan-tumor cohort and explored alternative… (Research Square)

Coverage, in order

  1. Research Square obscure study observational
    Real-world external validation of the Society for Immunotherapy of Cancer (SITC) definitions of primary and secondary resistance to PD-1/PD-L1 inhibitors in patients with solid tumors

    Purpose The Society for Immunotherapy of Cancer (SITC) definitions of primary and secondary resistance to PD-1/PD-L1 inhibitors are widely used but were independently evaluated mainly in melanoma. We assessed their prognostic performance in a real-world pan-tumor cohort and explored alternative…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.